These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function. Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317 [TBL] [Abstract][Full Text] [Related]
27. Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products. Brandau W; Bubeck B; Eisenhut M; Taylor DM Int J Rad Appl Instrum A; 1988; 39(2):121-9. PubMed ID: 2833469 [TBL] [Abstract][Full Text] [Related]
28. Searching for the ideal kidney agent. Britton KE Nucl Med Commun; 1986 Mar; 7(3):145-7. PubMed ID: 2940482 [No Abstract] [Full Text] [Related]
29. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH. Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976 [TBL] [Abstract][Full Text] [Related]
33. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples. Russell CD; Taylor A; Eshima D J Nucl Med; 1989 Dec; 30(12):1955-9. PubMed ID: 2531219 [TBL] [Abstract][Full Text] [Related]
34. Sequential Tc 99m mercaptoacetyl-triglycine (MAG3) renography as an evaluator of early renal transplant function. Carmody E; Greene A; Brennan P; Donohue J; Carmody M; Keeling F Clin Transplant; 1993 Jun; 7(3):245-9. PubMed ID: 10148844 [TBL] [Abstract][Full Text] [Related]
35. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate. Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350 [TBL] [Abstract][Full Text] [Related]
36. Renographic diagnosis of renovascular hypertension with angiotensin converting enzyme inhibition and furosemide. Sfakianakis GN; Bourgoignie JJ Am J Hypertens; 1991 Dec; 4(12 Pt 2):706S-710S. PubMed ID: 1837993 [TBL] [Abstract][Full Text] [Related]
37. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation. O'Malley JP; Ziessman HA; Chantarapitak N Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715 [TBL] [Abstract][Full Text] [Related]
38. Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure. Taylor A; Eshima D; Christian PE; Wooten WW; Hansen L; McElvany K J Nucl Med; 1988 May; 29(5):616-22. PubMed ID: 2967353 [TBL] [Abstract][Full Text] [Related]
39. Procedure guideline for diuretic renography in children. Society of Nuclear Medicine. Mandell GA; Cooper JA; Leonard JC; Majd M; Miller JH; Parisi MT; Sfakianakis GN J Nucl Med; 1997 Oct; 38(10):1647-50. PubMed ID: 9379208 [No Abstract] [Full Text] [Related]
40. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. Taylor A; Nally J; Aurell M; Blaufox D; Dondi M; Dubovsky E; Fine E; Fommei E; Geyskes G; Granerus G; Kahn D; Morton K; Oei HY; Russell C; Sfakianakis G; Fletcher J J Nucl Med; 1996 Nov; 37(11):1876-82. PubMed ID: 8917196 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]